A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer - Concepedia

Concepedia

Publication | Open Access

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer

DOI Full Paper Access

61

Citations

30

References

2015

Year

Lindsey E. Minion, Jiaru Bai, Bradley J. Monk, L. Robin Keller, Eskander N. Ramez, Gareth K. Forde, John K. Chan, Krishnansu S. Tewari

Gynecologic Oncology

Advanced Cervical CancerOncologyCervical CancerAntiangiogenesis TherapyCancer ManagementCost EffectivenessCancer TreatmentMarkov ModelMedicineRadiation OncologyTumor MicroenvironmentGynecology Oncology

References

	Year	Citations

Page 1

Page 1